Literature DB >> 30030017

Network-based predictions of in vivo cardiac hypertrophy.

Deborah U Frank1, Matthew D Sutcliffe2, Jeffrey J Saucerman3.   

Abstract

Cardiac hypertrophy is a common response of cardiac myocytes to stress and a predictor of heart failure. While in vitro cell culture studies have identified numerous molecular mechanisms driving hypertrophy, it is unclear to what extent these mechanisms can be integrated into a consistent framework predictive of in vivo phenotypes. To address this question, we investigate the degree to which an in vitro-based, manually curated computational model of the hypertrophy signaling network is able to predict in vivo hypertrophy of 52 cardiac-specific transgenic mice. After minor revisions motivated by in vivo literature, the model concordantly predicts the qualitative responses of 78% of output species and 69% of signaling intermediates within the network model. Analysis of four double-transgenic mouse models reveals that the computational model robustly predicts hypertrophic responses in mice subjected to multiple, simultaneous perturbations. Thus the model provides a framework with which to mechanistically integrate data from multiple laboratories and experimental systems to predict molecular regulation of cardiac hypertrophy.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac hypertrophy; Computational modeling; Heart failure; Systems biology; Transgenic mice

Mesh:

Substances:

Year:  2018        PMID: 30030017      PMCID: PMC6175293          DOI: 10.1016/j.yjmcc.2018.07.243

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  91 in total

Review 1.  Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.

Authors:  Beth A Rose; Thomas Force; Yibin Wang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

2.  Cardiomyopathy induced by cardiac Gs alpha overexpression.

Authors:  M Iwase; M Uechi; D E Vatner; K Asai; R P Shannon; R K Kudej; T E Wagner; D C Wight; T A Patrick; Y Ishikawa; C J Homcy; S F Vatner
Journal:  Am J Physiol       Date:  1997-01

3.  Dilated cardiomyopathy and sudden death resulting from constitutive activation of protein kinase a.

Authors:  C L Antos; N Frey; S O Marx; S Reiken; M Gaburjakova; J A Richardson; A R Marks; E N Olson
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

4.  The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy.

Authors:  P Liao; D Georgakopoulos; A Kovacs; M Zheng; D Lerner; H Pu; J Saffitz; K Chien; R P Xiao; D A Kass; Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

5.  Cardiac tissue enriched factors serum response factor and GATA-4 are mutual coregulators.

Authors:  N S Belaguli; J L Sepulveda; V Nigam; F Charron; M Nemer; R J Schwartz
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C.

Authors:  E G Stebbins; D Mochly-Rosen
Journal:  J Biol Chem       Date:  2001-05-31       Impact factor: 5.157

7.  The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice.

Authors:  Yuri Kim; Dillon Phan; Eva van Rooij; Da-Zhi Wang; John McAnally; Xiaoxia Qi; James A Richardson; Joseph A Hill; Rhonda Bassel-Duby; Eric N Olson
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

8.  Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice.

Authors:  C L Gruver; F DeMayo; M A Goldstein; A R Means
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

9.  Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation.

Authors:  Stefan Engelhardt; Lutz Hein; Vitaly Dyachenkow; Evangelia G Kranias; Gerrit Isenberg; Martin J Lohse
Journal:  Circulation       Date:  2004-02-16       Impact factor: 29.690

Review 10.  Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy.

Authors:  Shrey Kohli; Suchit Ahuja; Vibha Rani
Journal:  Curr Cardiol Rev       Date:  2011-11
View more
  9 in total

1.  The Impact of Hemodynamic Reflex Compensation Following Myocardial Infarction on Subsequent Ventricular Remodeling.

Authors:  Colleen Witzenburg; Jeffrey W Holmes
Journal:  J Biomech Eng       Date:  2019-05-29       Impact factor: 2.097

Review 2.  Emerging therapeutic targets for cardiac hypertrophy.

Authors:  Alexander J Winkle; Drew M Nassal; Rebecca Shaheen; Evelyn Thomas; Shivangi Mohta; Daniel Gratz; Seth H Weinberg; Thomas J Hund
Journal:  Expert Opin Ther Targets       Date:  2022-01-27       Impact factor: 6.902

3.  Bayesian calibration of a computational model of tissue expansion based on a porcine animal model.

Authors:  Tianhong Han; Taeksang Lee; Joanna Ledwon; Elbert Vaca; Sergey Turin; Aaron Kearney; Arun K Gosain; Adrian B Tepole
Journal:  Acta Biomater       Date:  2021-10-08       Impact factor: 8.947

Review 4.  Multiscale simulations of left ventricular growth and remodeling.

Authors:  Hossein Sharifi; Charles K Mann; Alexus L Rockward; Mohammad Mehri; Joy Mojumder; Lik-Chuan Lee; Kenneth S Campbell; Jonathan F Wenk
Journal:  Biophys Rev       Date:  2021-08-25

5.  Computational model predicts paracrine and intracellular drivers of fibroblast phenotype after myocardial infarction.

Authors:  Angela C Zeigler; Anders R Nelson; Anirudha S Chandrabhatla; Olga Brazhkina; Jeffrey W Holmes; Jeffrey J Saucerman
Journal:  Matrix Biol       Date:  2020-03-21       Impact factor: 11.583

Review 6.  Computational models of cardiac hypertrophy.

Authors:  Kyoko Yoshida; Jeffrey W Holmes
Journal:  Prog Biophys Mol Biol       Date:  2020-07-21       Impact factor: 3.667

7.  Computational model of cardiomyocyte apoptosis identifies mechanisms of tyrosine kinase inhibitor-induced cardiotoxicity.

Authors:  Monika E Grabowska; Bryan Chun; Raquel Moya; Jeffrey J Saucerman
Journal:  J Mol Cell Cardiol       Date:  2021-03-03       Impact factor: 5.763

8.  Network model-based screen for FDA-approved drugs affecting cardiac fibrosis.

Authors:  Angela C Zeigler; Anirudha S Chandrabhatla; Steven L Christiansen; Anders R Nelson; Jeffrey W Holmes; Jeffrey J Saucerman
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-02-27

Review 9.  Mechanical regulation of gene expression in cardiac myocytes and fibroblasts.

Authors:  Jeffrey J Saucerman; Philip M Tan; Kyle S Buchholz; Andrew D McCulloch; Jeffrey H Omens
Journal:  Nat Rev Cardiol       Date:  2019-06       Impact factor: 32.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.